search this site
- ir home
- about us
- investor relations
- Advisers/Registrars
- Annual/Interim Reports
- Online Interim Report
- Online Annual Report
- Investor Presentations
- Calculator & Graph
- Corporate Governance
- Corporate Social Responsibility
- Directors
- Financial Calendar
- Registration
- RNS News
- Share Price Information
- Major Shareholders
- Shareholdings and Electronic Voting
- Director's Share Dealings
- Analyst and Media Coverage
- contact us
Directors
Grahame Cook
Non-Executive Chairman
Mr Cook joined the Board in July 2004.
He has over 18 years' experience in
investment banking, advising on a
wide number of mergers and
acquisitions and capital market
transactions in the US and Europe.
He was Global CEO of West LB Panmure,
Managing Director of Capital Markets
and on the Global Investment Banking
Committee at UBS. He has advised
on a number of transactions in the
pharmaceuticals and biotechnology
sectors across Europe and the US,
including private equity investments,
IPOs and secondary offerings. Mr Cook
was a founder member of the LSE's
TechMARK Advisory Committee,
and holds an MA, double first, from
Oxford University. He is currently a
Non-Executive Director of Antisonna plc.
Chris Spooner
Chief Executive Officer
Chris Spooner was appointed CEO of Sinclair Pharma in December 2009. He has 15 years’ experience in analysing and investing in life science companies, having been a top-rated pharmaceuticals analyst at various investment banks, including JP Morgan, Deutsche Bank, Donaldson Lufkin & Jenrette and Bank of America. Prior to joining Sinclair he was the founding partner and CEO of HealthCor Management UK LLP, the European division of HealthCor LP, a leading New York based specialist healthcare fund. He holds an MA in Economics from King’s College, Cambridge.
Penny Freer
Non-Executive Director
Ms Freer has been involved in investment banking for 20 years. She co-founded The Capital Markets Group and until 2004 was Head of Equities for Robert W. Baird in London. She is a Non-Executive Director of Empresaria Group plc.
Jean-Charles Tschudin
Non-Executive Director
Mr Tschudin joined the Board in
November 2007. He has extensive
experience in the pharmaceutical
industry at a senior executive level
on three continents and was recently
President and Chief Operating Officer
of Yamanouchi Europe, the largest
Japanese company in Europe (now
Astellas). He has also held senior
positions at Johnson & Johnson,
Schering-Plough, Syntex and
Cardinal Health. Mr Tschudin is
currently Non-Executive Director of
SkyePharma plc and he also consults
for the pharma industry.
Christophe Foucher
Chief Operating Officer
Christophe was appointed General Manager in January 2008. In July 2008, he was appointed Southern Europe Director in charge of operations in Italy, Spain and Portugal. He has 14 years\' experience in the pharmaceutical industry at senior level in Europe, Africa and Asia. He has a doctorate degree in Pharmacy, an INSEAD diploma in Finance and an MBA from IAE. He is fluent in English, French and Italian.